Trials / Unknown
UnknownNCT04567719
Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer
The Role of Bladder Cancer TAS2R38 Expression on Chemotherapy-Induced Bitter Taste
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Alteration in the sense of taste is a frequent symptom that is closely linked to chemotherapy exposure, lowering quality of life and nutritional status. Malnutrition is of particular concern in muscle-invasive bladder cancer (MIBC), as malnutrition is associated with many negative outcomes from radical cystectomy (the surgical procedure in MIBC), which include higher morbidity, poor wound healing, and higher rate of infections after surgery. It is essential to understand taste changes among participants receiving chemotherapy for MIBC to create future treatment trials.
Conditions
Timeline
- Start date
- 2020-03-03
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2020-09-28
- Last updated
- 2024-02-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04567719. Inclusion in this directory is not an endorsement.